314 related articles for article (PubMed ID: 35965345)
1. Vaccines platforms and COVID-19: what you need to know.
Acosta-Coley I; Cervantes-Ceballos L; Tejeda-Benítez L; Sierra-Márquez L; Cabarcas-Montalvo M; García-Espiñeira M; Coronell-Rodríguez W; Arroyo-Salgado B
Trop Dis Travel Med Vaccines; 2022 Aug; 8(1):20. PubMed ID: 35965345
[TBL] [Abstract][Full Text] [Related]
2. Application of Traditional Vaccine Development Strategies to SARS-CoV-2.
Rando HM; Lordan R; Lee AJ; Naik A; Wellhausen N; Sell E; Kolla L; ; Gitter A; Greene CS
mSystems; 2023 Apr; 8(2):e0092722. PubMed ID: 36861991
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 Pandemic and Vaccines Update on Challenges and Resolutions.
Khan WH; Hashmi Z; Goel A; Ahmad R; Gupta K; Khan N; Alam I; Ahmed F; Ansari MA
Front Cell Infect Microbiol; 2021; 11():690621. PubMed ID: 34568087
[TBL] [Abstract][Full Text] [Related]
4. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
[TBL] [Abstract][Full Text] [Related]
5. An overview of the vaccine platforms to combat COVID-19 with a focus on the subunit vaccines.
Bayani F; Hashkavaei NS; Arjmand S; Rezaei S; Uskoković V; Alijanianzadeh M; Uversky VN; Ranaei Siadat SO; Mozaffari-Jovin S; Sefidbakht Y
Prog Biophys Mol Biol; 2023 Mar; 178():32-49. PubMed ID: 36801471
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV2 variant-specific replicating RNA vaccines protect from disease following challenge with heterologous variants of concern.
Hawman DW; Meade-White K; Archer J; Leventhal SS; Wilson D; Shaia C; Randall S; Khandhar AP; Krieger K; Hsiang TY; Gale M; Berglund P; Fuller DH; Feldmann H; Erasmus JH
Elife; 2022 Feb; 11():. PubMed ID: 35191378
[TBL] [Abstract][Full Text] [Related]
7. The Future of Epidemic and Pandemic Vaccines to Serve Global Public Health Needs.
Farlow A; Torreele E; Gray G; Ruxrungtham K; Rees H; Prasad S; Gomez C; Sall A; Magalhães J; Olliaro P; Terblanche P
Vaccines (Basel); 2023 Mar; 11(3):. PubMed ID: 36992275
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of Coronavirus Vaccines against Syndrome Coronavirus 2 (SARS-CoV-2) and Its New Variants.
Abdi Ghavidel A; Rojhannezhad M; Kazemi B; Bandehpour M
Iran J Allergy Asthma Immunol; 2021 Dec; 20(6):647-671. PubMed ID: 34920649
[TBL] [Abstract][Full Text] [Related]
9. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
Amanpour S
Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.
Garrett ME; Galloway JG; Wolf C; Logue JK; Franko N; Chu HY; Matsen FA; Overbaugh JM
Elife; 2022 Jan; 11():. PubMed ID: 35072628
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 will constantly sweep its tracks: a vaccine containing CpG motifs in 'lasso' for the multi-faced virus.
Oberemok VV; Laikova KV; Yurchenko KA; Marochkin NA; Fomochkina II; Kubyshkin AV
Inflamm Res; 2020 Sep; 69(9):801-812. PubMed ID: 32656668
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 vaccines: concerns beyond protective efficacy and safety.
Lai CC; Chen IT; Chao CM; Lee PI; Ko WC; Hsueh PR
Expert Rev Vaccines; 2021 Aug; 20(8):1013-1025. PubMed ID: 34180347
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 Vaccines: Where Are We Now?
Flanagan KL; MacIntyre CR; McIntyre PB; Nelson MR
J Allergy Clin Immunol Pract; 2021 Oct; 9(10):3535-3543. PubMed ID: 34400116
[TBL] [Abstract][Full Text] [Related]
14. Next-generation COVID-19 vaccines: Opportunities for vaccine development and challenges in tackling COVID-19.
Li Q; Wang J; Tang Y; Lu H
Drug Discov Ther; 2021; 15(3):118-123. PubMed ID: 34234059
[TBL] [Abstract][Full Text] [Related]
15. Antibody and Memory B-Cell Immunity in a Heterogeneously SARS-CoV-2-Infected and -Vaccinated Population.
Bednarski E; Del Rio Estrada PM; DaSilva J; Boukadida C; Zhang F; Luna-Villalobos YA; Rodríguez-Rangel X; Pitén-Isidro E; Luna-García E; Díaz Rivera D; López-Sánchez DM; Tapia-Trejo D; Soto-Nava M; Astorga-Castañeda M; Martínez-Moreno JO; Urbina-Granados GS; Jiménez-Jacinto JA; Serna Alvarado FJ; Enriquez-López YE; López-Arellano O; Reyes-Teran G; Bieniasz PD; Avila-Rios S; Hatziioannou T
mBio; 2022 Aug; 13(4):e0084022. PubMed ID: 35735743
[TBL] [Abstract][Full Text] [Related]
16. The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial.
Sudharsanan N; Favaretti C; Hachaturyan V; Bärnighausen T; Vandormael A
Trials; 2021 Sep; 22(1):592. PubMed ID: 34488843
[TBL] [Abstract][Full Text] [Related]
17. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
[TBL] [Abstract][Full Text] [Related]
18. Exigency of Plant-Based Vaccine against COVID-19 Emergence as Pandemic Preparedness.
Chattopadhyay A; Jailani AAK; Mandal B
Vaccines (Basel); 2023 Aug; 11(8):. PubMed ID: 37631915
[TBL] [Abstract][Full Text] [Related]
19. COVID-19: Prospective Challenges and Potential Vaccines.
Shahid Nadeem M; Ali A; Al-Ghamdi MA; Depfenhart M; Azam Khan J; Zamzami MA; Nazia Murtaza B; Kazmi I; Ur Rehman M
Altern Ther Health Med; 2020 Aug; 26(S2):72-78. PubMed ID: 32845250
[TBL] [Abstract][Full Text] [Related]
20. A review on the induction of host immunity by the current COVID-19 vaccines and a brief non-pharmaceutical intervention to mitigate the pandemic.
Noor R
Bull Natl Res Cent; 2022; 46(1):31. PubMed ID: 35194369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
